Unknown

Dataset Information

0

Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.


ABSTRACT: The years 1988-1995 witnessed the beginning of allergen cloning and the generation of recombinant allergens, which opened up new avenues for the diagnosis and research of human allergic diseases. Most crystal and solution structures of allergens have been obtained using recombinant allergens. Structural information on allergens allows insights into their evolutionary biology, illustrates clinically observed cross-reactivities, and makes the design of hypoallergenic derivatives for allergy vaccines possible. Recombinant allergens are widely used in molecule-based allergy diagnosis such as protein microarrays or suspension arrays. Recombinant technologies have been used to produce well-characterized, noncontaminated vaccine components with known biological activities including a variety of allergen derivatives with reduced IgE reactivity. Such recombinant hypoallergens as well as wild-type recombinant allergens have been used successfully in several immunotherapy trials for more than a decade to treat birch and grass pollen allergy. As a more recent application, the development of antibody repertoires directed against conformational epitopes during immunotherapy has been monitored by recombinant allergen chimeras. Although much progress has been made, the number and quality of recombinant allergens will undoubtedly increase and keep improving our knowledge in basic scientific investigations, diagnosis, and therapy of human allergic diseases.

PROVIDER: S-EPMC5472216 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC4397360 | BioStudies
| S-EPMC7404024 | BioStudies
| S-EPMC3660775 | BioStudies
2017-01-01 | S-EPMC5540349 | BioStudies
| S-EPMC5693727 | BioStudies
| S-EPMC6390931 | BioStudies
| S-EPMC6683018 | BioStudies
| S-EPMC7928321 | BioStudies
| S-EPMC4212987 | BioStudies
| S-EPMC4573524 | BioStudies